Urofollitropin - Ferring
Alternative Names: Bravelle; Ferring hFSH; HP FSH; Natural human follicle-stimulating hormone; Naturally derived follicle stimulating hormoneLatest Information Update: 24 Oct 2021
At a glance
- Originator Ferring Pharmaceuticals
- Class Follicle stimulating hormones; Infertility therapies; Menotropins; Pituitary gonadotropins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Female infertility
Most Recent Events
- 11 May 2017 No recent report on development identified - Phase-III for Female infertility in China (Parenteral)
- 01 Aug 2015 Ferring Pharmaceuticals completes a phase III trial for Female infertility in China (NCT01923194)
- 01 Apr 2015 Ferring Pharmaceuticals completes a phase III trial in Female infertility in China (NCT01922193)